SNOMED CT Concept  138875005

Pharmaceutical / biologic product  373873005

Medicinal product  763158003

Product manufactured as oral dose form  440131009

Dolutegravir-containing product in oral dose form  714768006

Dolutegravir- and lamivudine-containing product in oral dose form  787165000

Dolutegravir- and lamivudine- and tenofovir-containing product in oral dose form  1197404006

Dolutegravir and lamivudine and tenofovir only product in oral dose form  1197402005

Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet   1197400002

SNOMED CT code


SNOMED code1197400002
nameDolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet
statusactive
date introduced2022-02-28
fully specified name(s)Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug)
synonymsDolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet
attributes - group0
Has manufactured dose formOral tablet   421026006
Has unit of presentationTablet   732936001
Plays roleAntiretroviral therapeutic role   788073005
attributes - group1
Has precise active ingredientLamivudine   386897000
Has BoSSLamivudine   386897000
Has presentation strength numerator unitmg   258684004
Has presentation strength denominator unitTablet   732936001
attributes - group2
Has precise active ingredientTenofovir disoproxil fumarate   385556006
Has BoSSTenofovir disoproxil   421203005
Has presentation strength numerator unitmg   258684004
Has presentation strength denominator unitTablet   732936001
attributes - group3
Has precise active ingredientDolutegravir sodium   713465004
Has BoSSDolutegravir   713464000
Has presentation strength numerator unitmg   258684004
Has presentation strength denominator unitTablet   732936001
parentsDolutegravir and lamivudine and tenofovir only product in oral dose form   1197402005
hierarchies
a selection of possible paths
SNOMED CT Concept   138875005
  Pharmaceutical / biologic product   373873005
    Medicinal product   763158003
      Product manufactured as oral dose form   440131009
        Dolutegravir-containing product in oral dose form   714768006
          Dolutegravir- and lamivudine-containing product in oral dose form   787165000
            Dolutegravir- and lamivudine- and tenofovir-containing product in oral dose form   1197404006
              Dolutegravir and lamivudine and tenofovir only product in oral dose form   1197402005
                Dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet   1197400002

ancestors
sorted most to least specific
  • Dolutegravir and lamivudine and tenofovir only product in oral dose form   1197402005
  • Dolutegravir and lamivudine and tenofovir only product   1197401003
  • Dolutegravir- and lamivudine- and tenofovir-containing product in oral dose form   1197404006
  • Dolutegravir- and lamivudine- and tenofovir-containing product   1197403000
  • Lamivudine- and tenofovir-containing product in oral dose form   1268680004
  • Dolutegravir- and lamivudine-containing product in oral dose form   787165000
  • Lamivudine- and tenofovir-containing product   1268679002
  • Dolutegravir- and lamivudine-containing product   787163007
  • Lamivudine-containing product in oral dose form   714530007
  • Tenofovir-containing product in oral dose form   714402005
  • Dolutegravir-containing product in oral dose form   714768006
  • Lamivudine-containing product   108698001
  • Tenofovir-containing product   395264002
  • Dolutegravir-containing product   714767001
  • Product manufactured as oral dose form   440131009
  • Reverse transcriptase inhibitor-containing product   108709006
  • Pyrimidine-containing product   768609001
  • Nucleoside analog-containing product   768613008
  • Antiretroviral agent   788075003
  • Integrase strand transfer inhibitor-containing product   428617003
  • Carboxylic acid and/or carboxylic acid derivative-containing product   768626007
  • Nitrogen and/or nitrogen compound-containing product   768700009
  • Antiviral agent   788081006
  • Nucleotidyltransferase inhibitor-containing product   429168007
  • Organic acid and/or organic acid derivative-containing product   771260001
  • Transferase inhibitor-containing product   427059003
  • Medicinal product categorized by structure   763760008
  • Medicinal product categorized by therapeutic role   763087004
  • Enzyme inhibitor-containing product   407314008
  • Medicinal product categorized by disposition   766779001
  • Medicinal product   763158003
  • Pharmaceutical / biologic product   373873005
  • SNOMED CT Concept   138875005
cpt crosswalks

Rules-based maps relating CPT® codes to and from SNOMED CT® clinical concepts.  Forward and backward mapping allows for easy transition between code sets. Map-A-Code crosswalk tool easily crosswalks multiple codes between the code sets.

Access to this feature is available in the following products:
  • CPT® to SNOMED Crosswalks

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.